Home > Qtrly Results > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Quarterly Results Analysis [Mar2024]

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
Audited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹2,745 Cr ₹2,732 Cr ₹2,660 Cr ₹2,591 Cr ₹2,491 Cr ₹2,491 Cr ₹2,291 Cr ₹2,347 Cr
Expenses ₹1,862 Cr ₹1,863 Cr ₹1,835 Cr ₹1,800 Cr ₹1,764 Cr ₹1,767 Cr ₹1,612 Cr ₹1,635 Cr
Operating Income ₹883 Cr ₹869 Cr ₹825 Cr ₹791 Cr ₹727 Cr ₹724 Cr ₹679 Cr ₹712 Cr
Other Income ₹31 Cr ₹-33 Cr ₹26 Cr ₹34 Cr ₹9 Cr ₹-10 Cr ₹16 Cr ₹30 Cr
Interest ₹80 Cr ₹80 Cr ₹91 Cr ₹103 Cr ₹107 Cr ₹102 Cr ₹69 Cr ₹55 Cr
Depreciation ₹203 Cr ₹213 Cr ₹201 Cr ₹191 Cr ₹196 Cr ₹193 Cr ₹163 Cr ₹155 Cr
Profit Before Tax ₹631 Cr ₹631 Cr ₹559 Cr ₹531 Cr ₹433 Cr ₹419 Cr ₹463 Cr ₹532 Cr
Profit After Tax ₹449 Cr ₹443 Cr ₹386 Cr ₹378 Cr ₹287 Cr ₹292 Cr ₹312 Cr ₹354 Cr
EPS ₹13.27 ₹13.09 ₹11.40 ₹11.17 ₹8.48 ₹8.63 ₹9.22 ₹10.46
Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS 0.5% 2.7% 52%
SUN PHARMACEUTICAL INDUSTRIES -0% 5% 47.2%
CIPLA 0.3% -1.8% 47.2%
DR REDDYS LABORATORIES 3.2% 11.5% 30.2%
ZYDUS LIFESCIENCES 1.9% 9% 100.9%
DIVIS LABORATORIES 0.5% -0.4% 24.7%
MANKIND PHARMA 2.1% -4.1% 24.2%
LUPIN 1.1% 14.1% 96.9%
AUROBINDO PHARMA 3.1% 9.5% 80.3%

TORRENT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

0.48 %

Y-o-Y

10.20 %

Quarters Revenues % Change
Mar2024 ₹2,745 Cr
0.48
Dec2023 ₹2,732 Cr
2.71
Sep2023 ₹2,660 Cr
2.66
Jun2023 ₹2,591 Cr
4.01
Mar2023 ₹2,491 Cr
0.00
Dec2022 ₹2,491 Cr
8.73
Sep2022 ₹2,291 Cr
-2.39
Jun2022 ₹2,347 Cr -

TORRENT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

1.61 %

Y-o-Y

21.46 %

Quarters Operating Profit % Change
Mar2024 ₹883 Cr
1.61
Dec2023 ₹869 Cr
5.33
Sep2023 ₹825 Cr
4.30
Jun2023 ₹791 Cr
8.80
Mar2023 ₹727 Cr
0.41
Dec2022 ₹724 Cr
6.63
Sep2022 ₹679 Cr
-4.63
Jun2022 ₹712 Cr -
Operating Margins
Q-o-Q

1.13 %

Y-o-Y

10.21 %

Quarters Operating Margin% % Change
Mar2024 32.17%
1.13
Dec2023 31.81%
2.55
Sep2023 31.02%
1.60
Jun2023 30.53%
4.59
Mar2023 29.19%
0.45
Dec2022 29.06%
-1.96
Sep2022 29.64%
-2.31
Jun2022 30.34% -

TORRENT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

1.35 %

Y-o-Y

56.45 %

Quarters Profit After Tax % Change
Mar2024 ₹449 Cr
1.35
Dec2023 ₹443 Cr
14.77
Sep2023 ₹386 Cr
2.12
Jun2023 ₹378 Cr
31.71
Mar2023 ₹287 Cr
-1.71
Dec2022 ₹292 Cr
-6.41
Sep2022 ₹312 Cr
-11.86
Jun2022 ₹354 Cr -
PAT Margins
Q-o-Q

0.86 %

Y-o-Y

42.01 %

Quarters PAT Margin(%) % Change
Mar2024 16.36 %
0.86
Dec2023 16.22 %
11.78
Sep2023 14.51 %
-0.55
Jun2023 14.59 %
26.65
Mar2023 11.52 %
-1.71
Dec2022 11.72 %
-13.95
Sep2022 13.62 %
-9.68
Jun2022 15.08 % -

TORRENT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

1.38 %

Y-o-Y

56.49 %

Quarters EPS % Change
Mar2024 ₹13.27
1.38
Dec2023 ₹13.09
14.82
Sep2023 ₹11.4
2.06
Jun2023 ₹11.17
31.72
Mar2023 ₹8.48
-1.74
Dec2022 ₹8.63
-6.40
Sep2022 ₹9.22
-11.85
Jun2022 ₹10.46 -

You may also like the below Video Courses